The world market for toxicogenomics technologies is set to grow
strongly over the next five years, but needs the catalyst of
recognition by regulatory authorities.
A new report from Datamonitor predicts the end of the
pharmaceutical industry's blockbuster product model, pointing to a
dramatic shortfall in growth rates for billion dollar-plus products
out to 2008.
A conference on batch process automation and asset management in
the pharmaceutical industry is scheduled to take place in Cork,
Ireland, on 22-23 October.
The market for cell culture products is getting a lift from
stringent regulations from the US FDA and Department of
Agriculture, restricting the importation and usage of foetal bovine
serum
Sam Waksal, the disgraced former chief executive of US
biotechnology company ImClone Systems, is due for sentencing today
and could receive a jail sentence as well as significant fines.
US pharmaceutical major Eli Lilly has earmarked a hefty £220
million (€304 million) investment over the next four years in its
UK facilities, representing the largest investment by the firm in
any European country.
As this edition of In-pharmatechnologist.com goes online, the US
Food and Drug Administration is convening the inaugural meeting of
its Advisory Committee for Pharmaceutical Science's Manufacturing
Subcommittee.
The Smart Active Labels Consortium is to present its first seminar,
titled "Smart Active Labels for Temperature Tracking: Shaping
the Future of Food/Pharmaceutical Distribution," on June 10 -
11 in Chicago, US.
Attendance at SupplySide East earlier this month was slightly up on
last year, according to organisers, and although there were few
product launches, the conference provided all the drama.
Invensys APV, a supplier of process equipment to the pharmaceutical
industry, will demonstrate its new technologies at the upcoming
Achema 2003 exhibition in Frankfurt, Germany.
The addition of HarbourVest Partner to Israeli life sciences
venture capital fund Vitalife prompted the fund to announce on
Monday the closing of its first fund, worth €46 million.
US Neuro Bioscience has signed an agreement to acquire a minimum of
75 per cent of the issued and outstanding share capital of CLL
Pharma, a French company engaged in the business of reformulating
drugs using its proprietary drug...
German pharmaceutical and ingredients group Boehringer Ingelheim,
outpacing market growth, ended 2002 with a healthy rise in profits,
the company reports this week.
The European Federation of Biotechnology (EFB) is setting up a
trade office in Aarhus, Denmark for its activities in innovation
and functional genomics, reports Biotech Denmark on its website.
The latest data on cases of antibody-mediated pure red cell aplasia
associated with Johnson & Johnson subsidiary Janssen-Cilag's
erythropoietin product Eprex/Erypo (epoetin alfa) have suggested
that measures put in place...
Two British firms, De Novo Pharmaceuticals and Peakdale Molecular,
are to enter into a joint collaboration to exploit their respective
skills in molecular design and chemistry synthesis, writes market
analysts Datamonitor this week.
Biotechnology company Biogen this week celebrated its 25th
anniversary by breaking the ground on a large-scale manufacturing
facility in Hillerød, Denmark, marking the company's first
development phase for the region and a greater...
UK contract pharmaceutical manufacturer and distributor Intercare
Group has reported 2002 turnover of £275.1 million (€406m), an
increase of 27 per cent year-on-year, and pretax profits of £24.6
million, up 15 per cent. The results...
UK Science Minister Lord Sainsbury this week announced a new
initiative to develop 'a strategic approach' to the future of the
bioscience industry in the UK and to encourage growth in the
sector.
SC Biosciences is to be the exclusive distributor of sensitive
tools for drug discovery with the announcement this week that it
will distribute in vivo imaging technology in Japan for US company
Xenogen corporation.
German pharmaceutical company Boehringer Ingelheim has signed a
long-term agreement with software company MDL Information Systems
to use its software technology for managing and deploying chemical
information systems.
Applied Biosystems group, the world's number one maker of
gene-analysing equipment, warned on Tuesday that it would report
lower-than-expected fiscal third-quarter revenue and earnings due
to deteriorating business conditions.
Women are becoming the most attractive target audience for
healthcare companies, claims a new report from market analysts
Datamonitor. A combination of increasing Internet access, a general
interest in health issues among women along...
